Aspire Houston Fertility InstituteFebruary 6, 2020

FDA 483 - Aspire Houston Fertility Institute - February 06, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Aspire Houston Fertility Institute

Record Details

Aspire Fertility in Houston, TX was inspected from February 5-6, 2020, regarding its human reproductive tissue operations. The inspection revealed a significant lapse in donor screening procedures, specifically the failure to perform physical examinations for directed semen donors to screen for communicable disease agents. This indicates a potential risk related to the safety of human reproductive tissue.

Company: Aspire Houston Fertility Institute
Inspection Date: February 6, 2020
Product Type: Other
Office: Dallas District Office
Person: Erma Zaimova

Open in Dashboard

ID · 298011ba-b30e-4c82-874e-e3c38f7e43ad